Massachusetts Financial Services Co. MA Acquires 70,440 Shares of Masimo Co. (NASDAQ:MASI)

Massachusetts Financial Services Co. MA increased its holdings in shares of Masimo Co. (NASDAQ:MASI) by 9.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 792,166 shares of the medical equipment provider’s stock after purchasing an additional 70,440 shares during the quarter. Massachusetts Financial Services Co. MA owned 1.48% of Masimo worth $105,619,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Advisors Asset Management Inc. lifted its stake in Masimo by 3.7% during the 3rd quarter. Advisors Asset Management Inc. now owns 14,216 shares of the medical equipment provider’s stock valued at $1,895,000 after acquiring an additional 501 shares during the period. NS Partners Ltd lifted its position in Masimo by 2.3% during the third quarter. NS Partners Ltd now owns 43,037 shares of the medical equipment provider’s stock valued at $5,738,000 after purchasing an additional 986 shares during the period. Avior Wealth Management LLC boosted its holdings in Masimo by 16.5% in the third quarter. Avior Wealth Management LLC now owns 5,731 shares of the medical equipment provider’s stock worth $764,000 after purchasing an additional 812 shares during the last quarter. Quest Partners LLC grew its position in Masimo by 8,360.0% in the 3rd quarter. Quest Partners LLC now owns 2,115 shares of the medical equipment provider’s stock worth $282,000 after purchasing an additional 2,090 shares during the period. Finally, Empowered Funds LLC purchased a new stake in Masimo during the 3rd quarter valued at $279,000. 85.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MASI has been the topic of a number of research reports. Piper Sandler raised their price target on Masimo from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. BTIG Research boosted their price target on Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Raymond James upgraded shares of Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price objective on the stock in a research note on Wednesday, November 6th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research report on Wednesday, November 6th. Finally, Wells Fargo & Company upped their target price on shares of Masimo from $160.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Masimo presently has an average rating of “Moderate Buy” and a consensus price target of $167.00.

Masimo Trading Up 2.3 %

Masimo stock opened at $172.96 on Friday. Masimo Co. has a 12-month low of $91.60 and a 12-month high of $174.34. The firm has a market capitalization of $9.26 billion, a price-to-earnings ratio of 119.28 and a beta of 0.97. The firm has a 50 day moving average of $143.48 and a 200 day moving average of $128.00. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $502.87 million. During the same period in the prior year, the company posted $0.63 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, research analysts predict that Masimo Co. will post 4.04 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.